ArticleBMC medical research methodology2026
Recall bias in population-based case-control studies of ovarian cancer and genital talcum powder use: potential impact and quantitative bias analysis.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionQuantitative bias analysis (QBA) methods have been developed, with growing applications to epidemiological studies. Bayesian QBA (BQBA) methods may be superior in effectively using evidence-based priors and study data to displace fixed-value assumptions, and in characterizing distributions of adjusted point estimates and associated uncertainty.
methodsWe applied simple QBA (SQBA) and BQBA methods to population-based case-control studies on ovarian cancer and genital talcum powder use. Our hypothesis was that differential misclassification of self-reported historical talcum powder use led to statistically significant associations in several of these studies. SQBA results covering ranges of published exposure sensitivity and specificity estimates for genital talcum powder use were generated. BQBA models generated posterior means and 95% credible intervals (CrI’s) of bias-adjusted odds ratios (ORs), sensitivities and specificities of controls and cases, respectively, using pooled case-control study data.
resultsThe mean Bayesian posterior OR was 1.08 (95% CrI 0.67–1.77), mean case and control sensitivities were 0.87 and 0.78 and mean case and control specificities were 0.86 and 0.90, respectively. Model diagnostics indicated good fit.
conclusionUpon adjusting only for hypothesized differential exposure misclassification bias, the association between ovarian cancer and genital talcum powder use was attenuated relative to the unadjusted one. While other potential sources of bias may be operating within this body of studies, exposure reporting bias likely accounts for the statistically significant ORs reported in the individual case-control studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.